Joel Sandberg, M.D.
Joel Sandberg, M.D.

Presione aquí para Español

Joel Sandberg MDDr. Sandberg is a Board Certified ophthalmologist, a Fellow of the American Academy of Ophthalmology and a Fellow of the American College of Surgeons. He is a Voluntary Professor of Ophthalmology at the Bascom Palmer Eye Institute, University of Miami School of Medicine.

Dr. Sandberg was born in New York City. He received his B.A. degree Phi Beta Kappa from Johns Hopkins University, and his M.D. from the Johns Hopkins University School of Medicine, where he was elected to Alpha Omega Alpha, the National Medical Honor Society. He completed his medical internship at New York Hospital, Cornell Medical Center. Dr. Sandberg served two years in the United States Public Health Service doing cancer research at the NIH, then spent a year in Israel establishing a cancer chemotherapy program at Tel Hashomer Hospital. He completed his residency training in Ophthalmology at the Bascom Palmer Eye Institute and has remained active on the voluntary faculty.

Dr. Sandberg has served as President of the Miami Ophthalmologic Society and as Chairman of the Dept. of Ophthalmology of Hollywood Memorial Regional Hospital. He also served on the executive committee of the Florida Society of Ophthalmology and on the board of directors of the Memorial Same Day Surgery Center.

Dr. Sandberg has volunteered for surgical missions to third world countries to train local ophthalmologists in cataract and oculoplastic surgery. He has a particular interest in oculoplastic surgery (functional and cosmetic eyelid surgery, blepharoplasty, ptosis, ectropion, entropion, blocked tear ducts). He has lectured to physicians and community groups, published scientific articles, and participated in research studies on oculoplastic surgery, cataract and intraocular lens surgery, lasers, glaucoma, and the latest treatments for diabetic retinopathy and macula degeneration.


Location

Hollywood Office

2740 Hollywood Blvd.
Hollywood, FL 33020
954-925-2740
954-923-8379 (FAX)


Education

  • 1963-1967 John Hopkins University School of Medicine, M.D. Alpha Omega Alpha. American Cancer Society Research Scholarship.
  • 1960 - 1963 John Hopkins University, B.A. Phi Beta Kappa. AED (Honorary Pre-Medical Society). Vice President of Class, Honor Commission. Intercollegiate Basketball.

Post Doctoral Training

  • 1971-1974 Ophthalmology Residency, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida
  • 1970-1971 Cancer Chemotherapy Fellowship, Tel Hashomer Hospital, University of Tel Aviv Medical Center, Israel
  • 1968-1970 Staff Associate, Cancer Chemotherapy Research, National Cancer Institute, National Institute of Health, Bethesda, Maryland (U.S. Public Health Service)
  • 1967-1968 Medical Internship, New York Hospital - Sloan Kettering Memorial Hosptial, Cornell University School of Medicine, New York, New York.

Licensure and Board Certification

  • 1976 American Board of Ophthalmology
  • 1972 State of Florida
  • 1969 State of New York
  • 1967 State of Maryland

Academic & Administrative Appointments

  • 1976 - Present, Voluntary Faculty, Bascom Palmer Eye Institute, University of Miami School of Medicine: Instructor, Clinical Assistant Professor, Clinical Associate Professor, Voluntary Professor
  • 1987-1990, Surgical missions to Dominican Republic, Jamaica, and Antigua to train local ophthalmologists in cataract and eye plastic surgery
  • 1977 - Present, Instructor, Intraocular Implant Course, Cataract Surgical Congress; Lecturer to physicians and community groups in Broward County on eye care, macular degeneration, Diabetes 2000 and eye plastic surgery
  •  Voluntary Professor of Ophthalmology-  Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL

Hospital Appointments

  • Bascom Palmer Eye Institute Ann Bates Leach Eye Hospital
  • 1986-1988 Chairman, Department of Ophthalmology, Memorial Regional Hospital, Hollywood, Florida
  • Memorial Same Day Surgery Center
  • Hollywood Medical Center
  • North Miami Beach Surgical Center

Memberships, Offices and Committee Appointments

  • 1991-1996 Miami Ophthalmological Society, President, 1995-1996; Vice President, 1994-1995; Treasurer, 1993-1994; Corresponding Secretary, 1992-1993; Secretary, 1991-1992.
  • 1995-1996 Florida Society of Ophthalmology, Executive Committee
  • 1981-1990 Bascom Palmer Eye Institute Alumni Association, Executive Secretary
  • 1992-present Bascom Palmer Eye Institute, Co-Chairman Alumni Fund Campaign

Other Professional Positions & Major Appointments

  • 1977 Fellow, American Academy of Ophthalmology
  • 1978 Fellow, American College of Surgeons
  • American Medical Association
  • Florida Medical Association
  • Broward County Medical Association
  • American Intraocular Implant Society
  • Miami Ophthalmological Society
  • Florida Society of Ophthalmology

Publications

  • Sandberg, J.S., Brule, S., and Goldin, A. Antileukemic action of a new 4-carbon sugar dimethanesulfonate in mice. Proc. Amer. Assoc. Cancer Res. l0:75, l969.
  • Pujman, V., Sandberg, J.S., Howsden, L., and Goldin, A. Vliv chlorprothixenu, cytogranu a fluoxidinu na leukemii L1210. IXth Oncologic Conference, Bratislave, Czechoslovakia, October, l969.
  • Sandberg, J.S., and Goldin, A. Antileukemic action of a new sugar derivative dimethanesulfonate and related compounds in mice. Cancer Chemother. Rep. 53:367-376, l969.
  • Sandberg, J.S., Howsden, L., DeMarco, A., and Goldin, A. A comparison of the antileukemic effect in mice of adriamycin, a new antitumor antibiotic, with daunomycin. Cancer Chemother. Rep. 54:1-9, l970.
  • Pujman, V., Sandberg, J.S., Howsden, L., and Goldin, A. Combination chemotherapy of mouse leukemia L1210 with a neuroleptic and antimetabolites. Chemotherapy 15:105-110, 1970.
  • Sandberg, J.S., and Goldin, A. The use of leucovorin orally in normal and leukemic (L1210) mice to prevent the toxicity and gastrointestinal lesions of high dose methotrexate. Cancer Research. 30:1276-1280, May, l970.
  • Pujman, V., Sandberg, J., Howsden, L., and Goldin, A. The effect of Fluoxodine on L1210 leukemia in mice. Neoplasma 17,2. 1970.
  • Sandberg, J.S., and Goldin, A. The use of first generation transplants of a slow-growing solid tumor for the evaluation of new cancer chemotherapeutic agents. Cancer Chemother. Rep. 55:233-238, May, l970.
  • Sandberg, J.S., Owens, A.H., Jr., and Santos, G.W. Clinical and pathologic characteristics of graft versus host disease produced in cyclophosphamide treated adult mice. J. Natl. Cancer Inst. 46:l5l-160, Jan. l97l.
  • Goldin, A., Sandberg, J.S., and Henderson, E.S. The chemotherapy of human and animal acute leukemia. Cancer Chemother. Rep. 55:309-505, November, l97l.
  • Sandberg, J.S., Wood, H.B., Jr., Engle, R.R., Venditti, J.M. and Goldin, A., Methanesulfonates, the relationship of structure to antitumor activity. Cancer Chemother. Rep. (Suppl.) 3:l37-229, Nov. l972.
  • Sandberg, J.S. and Anderson, D.R. Immunosuppressive agents, Cytosine Arabinoside and Methotrexate by the Sub-Tenon's route of administration in the treatment of uveitis. Proc. of the Assoc. for Research in Vision and Ophthalmology, p. 28 #ll, l973.
  • Sandberg, J.S., and Goldhammer, Y. New Observations on Lens Disease. J. Israel Med. Assoc. 87:3l7-3l9, l974.
  • Sandberg, J.S. Tenth Annual Bascom Palmer Eye Institute Residents Day. Am. J. Ophthal. 78:1034-1040, Dec.1974.
  • Clayman, H.M., Sandberg, J.S., and Altman, R.D. Ocular Perforation in Pulseless Disease. Neuro- ophthalmology Vol. 8 Glaser and Smith eds. C.V. Mosby; pp. 292-295, l975.
  • Sandberg, J.S., Our Other Patients Behind the Red Curtin. Miami Medicine, 54: l8-20-, l984.
  • Sandberg, J.S., Mission Eye Surgery in the Dominican Repbublic, Ocular Surg. News 6(5)16, March 1, 1988.
  • Rusk, C., Sharpe, E., Laurence, J., Polis, A., Adamsons, I., and the Dorzolamide Comparison Study Group, Comparison of the Efficacy and Safety of 2% Dorzolamide and 0.5% Betaxolol in the Treatment of Elevated Intraocular Pressure - Clinical Therapeutics Vol. 20 No. 3 May-June 1998



 

Recommend This Page To Your Friend

View Default message added